Zobrazeno 1 - 7
of 7
pro vyhledávání: '"T D, Theodoridis"'
Autor:
D, Vavilis, K, Chatzigeorgiou, D, Goulis, K, Pantazis, A, Papanicolaou, T D, Theodoridis, B C, Tarlatzis
Publikováno v:
European journal of gynaecological oncology. 32(5)
In this survey we evaluated the prescription attitude of Greek gynecologists towards hormone replacement therapy (HRT) for ovarian cancer survivors.An anonymous questionnaire was sent to 900 members of the Hellenic Society of Obstetrics and Gynecolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::09874004c16329ecc7b76e60c9308017
https://pubmed.ncbi.nlm.nih.gov/22053670
https://pubmed.ncbi.nlm.nih.gov/22053670
Autor:
T D, Theodoridis, K N, Chatzigeorgiou, L, Zepiridis, A, Papanicolaou, D, Vavilis, F, Tzevelekis, B C, Tarlatzis
Publikováno v:
Clinical and experimental obstetricsgynecology. 38(1)
Surgical site infections (SSIs) after cesarean section appear to be more common than generally believed. We prospectively evaluated 231 consecutive pregnant women who underwent elective or emergency cesarean section, and were assigned to have either
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ea69d011ad40aba81beebcccf9e581e8
https://pubmed.ncbi.nlm.nih.gov/21485728
https://pubmed.ncbi.nlm.nih.gov/21485728
Publikováno v:
European journal of gynaecological oncology. 30(4)
Leiomyosarcomas of the broad ligament of the uterus are extremely rare tumors. Most of the time they are diagnosed in older women and despite radical surgical treatment prognosis is dismal. We present a rare case of a 38-year-old nulligravida present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::35d28efe38abf483c828f26a5e5e613e
https://pubmed.ncbi.nlm.nih.gov/19761145
https://pubmed.ncbi.nlm.nih.gov/19761145
Publikováno v:
European journal of gynaecological oncology. 30(3)
Ovarian hilus or Leydig cell tumor and ovarian hilus cell hyperplasia are rare clinical entities, causing virilization in both pre- and postmenopausal women. Differentiation between these two conditions is not always straightforward; the former is us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::79505910cc395475a6b225081f502bd7
https://pubmed.ncbi.nlm.nih.gov/19697637
https://pubmed.ncbi.nlm.nih.gov/19697637
Autor:
M, Zafrakas, L, Zepiridis, T D, Theodoridis, I D, Venizelos, A, Papanicolaou, T, Agorastos, J N, Bontis
Publikováno v:
European journal of gynaecological oncology. 30(3)
Multiple clinical trials in recent years have shown that breast cancer patients with primary tumors overexpressing ERBB2 can be effectively treated with specific forms of modern anti-ERBB2-targeted therapy. The aim of the present study was to analyze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57485a26def63cf20d90e254aeac2daf
https://pubmed.ncbi.nlm.nih.gov/19697624
https://pubmed.ncbi.nlm.nih.gov/19697624
Publikováno v:
European journal of gynaecological oncology. 30(2)
Metastases from malignancies of the female genital tract to the tonsils have never been reported. A case of a 55-year-old woman presenting with a palatinate tonsil tumour two and half years after primary diagnosis of endometrioid endometrial adenocar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18e2bf798c6391672e26fda162ee316e
https://pubmed.ncbi.nlm.nih.gov/19480265
https://pubmed.ncbi.nlm.nih.gov/19480265
Publikováno v:
European journal of gynaecological oncology. 29(3)
The aim of the present study was to investigate the possibility of treating uterine sarcomas with imatinib mesylate. Imatinib mesylate, a selective tyrosine kinase inhibitor, is very efficient against mesenchymal tumors of the gastrointestinal tract,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ad507a4fce2951d4e8ac9284961abb0d
https://pubmed.ncbi.nlm.nih.gov/18592792
https://pubmed.ncbi.nlm.nih.gov/18592792